Literature DB >> 2455577

Adenosine inhibits the positive inotropic effect of 3-isobutyl-1-methylxanthine in papillary muscles without effect on cyclic AMP or cyclic GMP.

M Böhm1, R Brückner, J Neumann, M Nose, W Schmitz, H Scholz.   

Abstract

1 Adenosine and the adenosine receptor agonist (-)-N6-phenylisopropyladenosine (PIA) produced a small positive and negative inotropic effect, respectively, in isolated electrically driven papillary muscles of guinea-pigs. 2 Adenosine (100 mumol l-1) had no effect on cyclic AMP or cyclic GMP content. PIA (100 mumol l-1) slightly increased cyclic AMP. 3 In the presence of 3-isobutyl-1-methylxanthine (IBMX; 60 mumol l-1), which increased force of contraction 2 fold, adenosine and PIA exerted strong negative inotropic effects. PIA was more potent than adenosine (mean IC25 2.1 and 168 mumol -1, respectively). 4 In contrast, the nucleosides did not affect the increase in force of contraction produced by elevating extracellular Ca2+ concentration. 5 The IBMX-antagonistic effects of adenosine and PIA were not accompanied by modification of the IBMX-induced increase in cyclic AMP and cyclic GMP. 6 The effects of adenosine and PIA on force of contraction were accompanied by a partial reversal of the IBMX-induced increase in the maximal rate of depolarization of slow action potentials. 7 It is concluded that adenosine and PIA are able to attenuate the positive inotropic effect of a phosphodiesterase inhibitor. This effect is unlikely to be due to a reduction of the IBMX-induced increase in cyclic AMP content. It is conceivably due to an inhibition of the stimulant action of cyclic AMP on slow Ca2+ channels leading to the reduction of the slow inward current which in turn reduces force of contraction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455577      PMCID: PMC1853904          DOI: 10.1111/j.1476-5381.1988.tb11456.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Reduction by adenosine of the isoproterenol-induced increase in cyclic adenosine 3',5'-monophosphate formation and glycogen phosphorylase activity in rat heart muscle.

Authors:  J G Dobson
Journal:  Circ Res       Date:  1978-11       Impact factor: 17.367

2.  Adenosine as inhibitor of myocardial effects of catecholamines.

Authors:  J Schrader; G Baumann; E Gerlach
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

3.  Effectiveness of theophylline to increase cyclic AMP levels and force of contraction in electrically paced guinea-pig auricles. Comparison with isoprenaline, calcium and ouabain.

Authors:  C Dönges; M Heitmann; H Jungbluth; T Meinertz; B Schmelzle; H Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-12       Impact factor: 3.000

4.  Interaction between adenosine and catecholamines on cyclic AMP accumulation in guinea pig ventricular myocardium.

Authors:  M Huang; G I Drummond
Journal:  Biochem Pharmacol       Date:  1978-01-15       Impact factor: 5.858

5.  Comparison of the biochemical composition of four preparations of contracting cardiac muscle.

Authors:  J G Dobson; G E Schwab; J Ross; S E Mayer
Journal:  Am J Physiol       Date:  1974-12

6.  Influence of isoproterenol and methylisobutylxanthine on the contractile and cyclic nucleotide effects of methacholine in isolated rat atria.

Authors:  B S Brown; J B Polson; J J Krzanowski; J R Wiggins
Journal:  J Pharmacol Exp Ther       Date:  1980-02       Impact factor: 4.030

7.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

8.  Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

Authors:  J F Harper; G Brooker
Journal:  J Cyclic Nucleotide Res       Date:  1975

9.  Solid phase radioimmunoassay for cyclic AMP using staphylococcal protein A-antibody adsorbent.

Authors:  C J Struck; G Ahnert; H Glossmann; W Schaeg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

10.  Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.

Authors:  C Berger; W Meyer; H Scholz; J Starbatty
Journal:  Arzneimittelforschung       Date:  1985
View more
  9 in total

1.  Studies on the cellular mechanisms of action of positive and negative inotropic agents.

Authors:  A M Watanabe; F Green; Z Ahmad
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

2.  Pharmacological characteristics of adenosine-induced inhibition of dog ventricular contractility: dependence on the pre-existing level of beta-adrenoceptor activation.

Authors:  M Endoh; H Kushida; I Norota; M Takanashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

Review 3.  The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.

Authors:  Joachim Neumann; Uwe Kirchhefer; Stefan Dhein; Britt Hofmann; Ulrich Gergs
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

4.  Slowing of shortening velocity of rat cardiac myocytes by adenosine receptor stimulation regardless of beta-adrenergic stimulation.

Authors:  K T Strang; R M Mentzer; R L Moss
Journal:  J Physiol       Date:  1995-08-01       Impact factor: 5.182

5.  Genetic disruption of G proteins, G(i2)alpha or G(o)alpha, does not abolish inotropic and chronotropic effects of stimulating muscarinic cholinoceptors in atrium.

Authors:  P Boknik; S Grote-Wessels; G Barteska; M Jiang; F U Müller; W Schmitz; J Neumann; L Birnbaumer
Journal:  Br J Pharmacol       Date:  2009-11       Impact factor: 8.739

6.  Blockade of adenosine receptors unmasks a stimulatory effect of ATP on cardiac contractility.

Authors:  L Mantelli; S Amerini; S Filippi; F Ledda
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.

Authors:  D G Wynne; P A Poole-Wilson; S E Harding
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Pronounced direct inhibitory action mediated by adenosine A1 receptor and pertussis toxin-sensitive G protein on the ferret ventricular contraction.

Authors:  M Endoh; M Takanashi; I Norota; Y Kawabata; T Asano
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

9.  Characterization of adenosine receptors in guinea-pig isolated left atria.

Authors:  U Jahnel; H Nawrath
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.